AN2 Therapeutics

Fund: 2018
Sector: Life Sciences

AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on novel medicines targeting infectious diseases.

visit website

Appello Pharmaceuticals

Fund: 2018
Sector: Life Sciences

Appello Pharmaceuticals is a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.

visit website

Boragen

Fund: 2018
Sector: Life Sciences

Boragen is a small molecule development company focused on leveraging the unique chemical properties of Boron chemistry, both in crop protection and animal health.

visit website

Castle Biosciences

Fund: 2013, 2018
Sector: Life Sciences

Castle Biosciences is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA.

visit website

Cerebrotech Medical Systems

Fund: 2013, 2018
Sector: Life Sciences

Cerebrotech Medical Systems has developed a non-invasive, continuous monitor for early detection of cerebral fluid change (primarily edema or bleeding) that can occur in a number of neurologic conditions, including stroke, traumatic brain injury, post brain surgery, etc.

visit website

Mindera Health

Fund: 2018
Sector: Life Sciences

Mindera Health has developed a proprietary micro biopsy tool used to extract a patient’s transcriptome. After processing via next-generation sequencing and analysis, dermatologists will be able to make personalized diagnoses and track disease progression.

visit website

PhaseBio Pharmaceuticals

Fund: 2018
Sector: Life Sciences

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications.

visit website